EFFICACY AND SAFETY OF COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE CHRONOS-1 STUDY

被引：0

作者：

Zinzani, P. L. ^{[1
]}

Santoro, A. ^{[2
]}

Leppa, S. ^{[3
]}

Demeter, J. ^{[4
]}

Follows, G. A. ^{[5
]}

Lenz, G. ^{[6
]}

Kim, W. S. ^{[7
]}

Mollica, L. ^{[8
]}

Nagler, A. ^{[9
]}

Diong, C. P. ^{[10
]}

Provenciio, M. ^{[11
]}

Stevens, D. A. ^{[12
]}

Trevarthen, D. ^{[13
]}

Maagnoli, M. ^{[2
]}

Cupit, L. ^{[14
]}

Yin, S. ^{[14
]}

Hiemeyer, F. ^{[15
]}

Garcia-Vargas, J. ^{[14
]}

Childs, B. H. ^{[14
]}

Dreyling, M. ^{[16
]}

机构：

[1] Univ Bologna, Dept Hematol, Inst Hematol L&A Seragnoli, Bologna, Italy

[2] Humanitas Res Hosp, Dept Hematol & Oncol, Humanitas Canc Ctr, Rozzano, Italy

[3] Univ Helsinki, Cent Hosp, Ctr Canc, Dept Oncol, Helsinki, Finland

[4] Semmelweis Univ, Div Haematol, Dept Internal Med 1, Budapest, Hungary

[5] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge, England

[6] Univ Hosp Munster, Translat Oncol, Munster, Germany

[7] Sungkyunkwan Univ, Div Hematol & Oncol, Dept Med, Sch Med,Samsung Med Ctr, Seoul, South Korea

[8] Hop Maisonneuve Rosemont Montreal, Dept Hematol, Montreal, PQ, Canada

[9] Tel Aviv Univ, Chaim Sheba Med Ctr, Hematol Div, Tel Hashomer, Israel

[10] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore

[11] Univ Autonoma Madrid, Hosp Univ Puerta de Hierro, Hlth Res Inst, Madrid, Spain

[12] Norton Canc Inst, Louisville, KY USA

[13] Comprehens Canc Care & Res Inst Colorado, Englewood, CO, Angola

[14] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[15] Bayer AG, Berlin, Germany

[16] Klinikum Univ Munchen LMU, Med Klin & Poliklin 3, Munich, Germany

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S776

引用

页码：314 / 315

页数：2

共 50 条

[1] Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial
Dreyling, Martin
Panayiotidis, Panayiotis
Egyed, Miklos
Follows, George
Mollica, Luigina
Nagler, Arnon
Ozcan, Muhit
Santoro, Armando
Ishida, Tatiane
Lu, Cindy
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
[J]. BLOOD, 2017, 130
[2] Efficacy of Copanlisib Monotherapy in Patients With Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis From the CHRONOS-1 Trial
Martin, Peter
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 10 - 11
[3] Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma
Dreyling, Martin H.
Santoro, Armando
Leppa, Sirpa
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Magagnoli, Massimo
Radinoff, Atanas
Munoz, Javier
Cao, Anjun
Hiemeyer, Florian
Odongo, Fatuma
Garcia-Vargas, Jose E.
Childs, Barrett H.
Zinzani, Pier Luigi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[4] Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don
Trevarthen, David
Rodrigues, Liana
Hiemeyer, Florian
Wang, MingLu
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
[J]. BLOOD, 2018, 132
[5] Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don A.
Trevarthen, David
Giurescu, Marius
Kupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
[J]. CANCER RESEARCH, 2017, 77
[6] Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study
Dreyling, M.
Santoro, A.
Mollica, L.
Leppa, S.
Follows, G. A.
Lenz, G.
Kim, W. S.
Nagler, A.
Panayiotidis, P.
Demeter, J.
Ozcan, M.
Kosinova, M.
Bouabdallah, K.
Morschhauser, F.
Stevens, D. A.
Trevarthen, D.
Giurescu, M.
Kupit, L.
Childs, B. H.
Zinzani, P. L.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 12 - 12
[7] Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study
Provencio Pulla, M.
Santoro, A.
Mollica, L.
Leppa, S.
Follows, G.
Lenz, G.
Kim, W. S.
Nagler, A.
Panayiotidis, P.
Demeter, J.
Ozcan, M.
Kosinova, M.
Bouabdallah, K.
Morschhauser, F.
Ishida, T.
Huang, L.
Garcia-Vargas, J.
Childs, B. H.
Zinzani, P. L.
Dreyling, M.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[8] Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Dimou, Maria
Demeter, Judit
Magagnoli, Massimo
Rodrigues, Liana
Wirtz, Oliver
Hiemeyer, Florian
Liu, Li
Koechert, Karl
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin H.
[J]. BLOOD, 2018, 132
[9] Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6-year follow-up of CHRONOS-1
Dreyling, M.
Santoro, A.
Mollica, L.
Leppa, S.
Follows, G.
Lenz, G.
Kim, W. S.
Nagler, A.
Panayiotidis, P.
Ozcan, M.
Kosinova, M.
Provencio, M.
Magagnoli, M.
Bouabdallah, K.
Diong, C. Phipps
Munoz, J.
Cao, A.
Hiemeyer, F.
Odongo, F.
Garcia-Vargas, J.
Childs, B.
Zinzani, P. L.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 51 - 52
[10] Copanlisib in patients with relapsed or refractory follicular lymphoma.
Dreyling, Martin H.
Santoro, Armando
Leppa, Sirpa
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David
Magagnoli, Massimo
Cupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
-Vargas, Jose E. Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →